Keep up-to-date with Shimmer
Shimmer Launches Pulse+ the First Line Extension for its Verisense® Wearable Sensing Platform
CAMBRIDGE, MA – March 2, 2021 – Shimmer Research, a global leader in wearable technology for research applications, today launched Verisense Pulse+, a new sensor for the Verisense platform. Verisense Pulse+ provides photoplethysmogram (PPG), galvanic skin response (GSR), and an inertial measurement unit (IMU). The Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.
The PPG sensor monitors heart rate by using light absorption to measure changes in participant capillary blood volume. Whereas the GSR sensor measures changes in sweat gland activity, which can be used to assess the participant’s level of psychological and emotional arousal, stress, and other emotional responses. GSR is used for psychology clinical research and biofeedback, and it is starting to be employed in more clinical applications, including epilepsy.
“We are excited to introduce Verisense Pulse+ to the clinical trial market and integrate these new senor capabilities into our platform,” said Geoffrey Gill, President of Shimmer Americas. “Worn on the wrist, Pulse+ has all the attributes that researchers look for in the Verisense platform. It is versatile and reliable (provides 24x7 continuous raw data) with water resistant, flexible styling. Verisense Pulse+ provides access to high quality raw data, while placing minimum burden on sponsors, clinical trial sites, and participants. It’s also easy to use because all the sensors are employed on the same architecture.”
“After an extensive evaluation of all the on-market wearable sensor products, we determined that Verisense Pulse+ was the only one that could give us the raw data that we needed to study depression relapse thoroughly so we could create a tool to manage it effectively. We decided to become a Pulse+ beta tester and found the Shimmer team to be very collaborative and resourceful partners,” said Dr. Dilpreet Buxi, CTO and co-founder of Philia Labs.
Verisense is a highly flexible, modular patent-pending platform designed from the ground up to meet the needs of clinical trials and remote patient research. Additional information about this new product can be found at www.verisense.net.
Shimmer experts will also be available to answer questions about Verisense Pulse+ in the Virtual Sponsors and Exhibitors Hall at the SCOPE Virtual Summit for Clinical Ops Executives from March 2-4. Exhibit hours can be found at https://www.scopesummit.com/Exhibit-Services-Schedule. Shimmer will also be giving a brief presentation in the Solutions Theatre at 12:35 pm EST on March 3.
About Shimmer Research
Founded based on Intel technology in 2006, Shimmer Research is a well-established wearable technologies services and sensor manufacturing company based in Dublin, Ireland. In addition to standard products, Shimmer provides customized sensor development services, volume manufacturing, and complete wearable sensor solutions of any complexity. Shimmer’s technology and services have been employed by thousands of researchers at more than 900 leading companies, universities, and research institutes in more than 75 countries. Shimmer’s technology is incorporated in the products and services of more than 20 original equipment manufacturers. Shimmer has an ISO 13485:2016 certified medical devices quality management system. For more information, visit www.shimmersensing.com, https://www.linkedin.com/company/shimmer/ or follow @ShimmerSensing.